SIG Stock Overview
Engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 6/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Sigma Healthcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$2.56 |
52 Week High | AU$2.71 |
52 Week Low | AU$0.69 |
Beta | 0.15 |
11 Month Change | 38.01% |
3 Month Change | 106.45% |
1 Year Change | 268.35% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 255.56% |
Recent News & Updates
Recent updates
Shareholder Returns
SIG | AU Healthcare | AU Market | |
---|---|---|---|
7D | 7.8% | 1.2% | 0.9% |
1Y | 268.3% | 4.3% | 17.7% |
Return vs Industry: SIG exceeded the Australian Healthcare industry which returned 4.3% over the past year.
Return vs Market: SIG exceeded the Australian Market which returned 17.7% over the past year.
Price Volatility
SIG volatility | |
---|---|
SIG Average Weekly Movement | 10.8% |
Healthcare Industry Average Movement | 4.9% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 17.2% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: SIG has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: SIG's weekly volatility (11%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1912 | n/a | Vikesh Ramsunder | www.sigmahealthcare.com.au |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners.
Sigma Healthcare Limited Fundamentals Summary
SIG fundamental statistics | |
---|---|
Market cap | AU$4.01b |
Earnings (TTM) | -AU$3.00m |
Revenue (TTM) | AU$3.48b |
1.2x
P/S Ratio-1,334x
P/E RatioIs SIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SIG income statement (TTM) | |
---|---|
Revenue | AU$3.48b |
Cost of Revenue | AU$3.25b |
Gross Profit | AU$227.81m |
Other Expenses | AU$230.81m |
Earnings | -AU$3.00m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0019 |
Gross Margin | 6.55% |
Net Profit Margin | -0.086% |
Debt/Equity Ratio | 0% |
How did SIG perform over the long term?
See historical performance and comparison